- Home
- CHRS vs TDUP Comparison
CHRS vs TDUP Comparison
Compare CHRS & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- TDUP
- Stock Information
- Founded
- CHRS 2010
- TDUP 2009
- Country
- CHRS United States
- TDUP United States
- Employees
- CHRS N/A
- TDUP N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- TDUP Catalog/Specialty Distribution
- Sector
- CHRS Health Care
- TDUP Consumer Discretionary
- Exchange
- CHRS Nasdaq
- TDUP Nasdaq
- Market Cap
- CHRS 84.2M
- TDUP 927.1M
- IPO Year
- CHRS 2014
- TDUP 2021
- Fundamental
- Price
- CHRS $0.90
- TDUP $7.08
- Analyst Decision
- CHRS Buy
- TDUP Buy
- Analyst Count
- CHRS 3
- TDUP 3
- Target Price
- CHRS $4.68
- TDUP $7.25
- AVG Volume (30 Days)
- CHRS 1.2M
- TDUP 2.8M
- Earning Date
- CHRS 08-07-2025
- TDUP 08-04-2025
- Dividend Yield
- CHRS N/A
- TDUP N/A
- EPS Growth
- CHRS N/A
- TDUP N/A
- EPS
- CHRS N/A
- TDUP N/A
- Revenue
- CHRS $272,251,000.00
- TDUP $266,789,000.00
- Revenue This Year
- CHRS N/A
- TDUP $12.30
- Revenue Next Year
- CHRS $106.56
- TDUP $7.59
- P/E Ratio
- CHRS N/A
- TDUP N/A
- Revenue Growth
- CHRS 19.87
- TDUP 7.96
- 52 Week Low
- CHRS $0.66
- TDUP $0.50
- 52 Week High
- CHRS $2.43
- TDUP $8.75
- Technical
- Relative Strength Index (RSI)
- CHRS 59.04
- TDUP 46.04
- Support Level
- CHRS $0.73
- TDUP $6.59
- Resistance Level
- CHRS $0.82
- TDUP $8.00
- Average True Range (ATR)
- CHRS 0.04
- TDUP 0.52
- MACD
- CHRS 0.02
- TDUP -0.18
- Stochastic Oscillator
- CHRS 88.02
- TDUP 23.22
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About TDUP ThredUp Inc.
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.